PRospective Multiple Myeloma Impact Study (PROMMIS)

Clinical Trial Details

This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in Multiple Myeloma patients.

Key Eligibility: 

Inclusion Criteria

  • Potentially multiple myeloma according to IMWG criteria
  • Candidates for systemic treatment

Exclusion Criteria

  • ECOG Performance Status greater than 3
  • Tumor sample that fails QA or QC criteria for MMprofiler

Study contact by location

Upper East Side - Manhattan

Contact(s)

Kathleen Pogonowski, RN
(646) 962-6500
kap9111@med.cornell.edu

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

1706018339

ClinicalTrials.gov:

NCT02911571

Sponsor:

PROMMIS

Status

Open to Enrollment

Age Group

Adult

Sponsor